Bio Preventive Medicine Corp.
Bio Preventive Medicine Corp., a clinical-staged biotech company, focusing on early detection and prevention of diseases. The company offers solutions in prevention, screening, and monitoring chronic diseases and cancers management. It also provides DNlite test, a series of patented and clinically validated non-invasive urine test for monitoring the progression of diabetic nephropathy, including … Read more
Market Cap & Net Worth: Bio Preventive Medicine Corp. (6810)
Bio Preventive Medicine Corp. (TWO:6810) has a market capitalization of $25.93 Million (NT$857.93 Million) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #46037 globally and #2040 in its home market, demonstrating a -4.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bio Preventive Medicine Corp.'s stock price NT$17.35 by its total outstanding shares 49448500 (49.45 Million).
Bio Preventive Medicine Corp. Market Cap History: 2026 to 2026
Bio Preventive Medicine Corp.'s market capitalization history from 2026 to 2026. Data shows growth from $25.93 Million to $25.93 Million (0.00% CAGR).
Bio Preventive Medicine Corp. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bio Preventive Medicine Corp.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6810 by Market Capitalization
Companies near Bio Preventive Medicine Corp. in the global market cap rankings as of March 19, 2026.
Key companies related to Bio Preventive Medicine Corp. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Bio Preventive Medicine Corp. Historical Marketcap From 2026 to 2026
Between 2026 and today, Bio Preventive Medicine Corp.'s market cap moved from $25.93 Million to $ 25.93 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$25.93 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Bio Preventive Medicine Corp. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $25.93 Million USD |
| MoneyControl | $25.93 Million USD |
| MarketWatch | $25.93 Million USD |
| marketcap.company | $25.93 Million USD |
| Reuters | $25.93 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.